The Mapping America's Pharmaceutical Supply Act requires the federal government to identify and monitor essential medicines that are critical for public health and national security. The bill directs the Secretary of Health and Human Services to create and maintain a list of essential medicines—including those needed for emergency response, chronic disease treatment, and military preparedness—updating it at least every two years, with the first update due within 180 days of enactment. The government must also conduct a comprehensive risk assessment of the supply chains for these medicines, identifying which ones depend heavily on foreign suppliers, particularly from countries of concern, and which ones are vulnerable to shortages or cyberattacks; this assessment will be reported to Congress annually, with a public version released within one year. Additionally, the bill requires the federal government to map pharmaceutical supply chains using data analytics to spot vulnerabilities, with detailed reporting to Congress every 18 months, and requires the Department of Defense to report every six months on any military drugs that rely on materials or manufacturing from China. The legislation establishes no new dedicated funding but enables federal agencies to share confidential commercial information needed to protect pharmaceutical supply chains while maintaining cybersecurity safeguards.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.